Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Asian Stocks Mainly Up Over Vaccine Hopes, But Risks Remain

Published 07/14/2020, 10:46 PM
Updated 07/14/2020, 10:50 PM
© Reuters.

© Reuters.

By Gina Lee

Investing.com – Asian stocks were mostly up on Wednesday, with investors cheered by positive data for a potential COVID-19 vaccine.

U.S. biotech firm Moderna Inc (NASDAQ:MRNA)'s experimental COVID-19 vaccine was declared safe and generated “robust” immune responses in all 45 volunteers taking part in the study, according to early-stage human trial results published in the New England Journal of Medicine on Tuesday.

The data boosted hopes of a cure for the virus, but some investors warned that the ever-rising number of cases and re-imposition of lockdowns remain risks.

"Markets have shown a remarkable ability to look through rising infection rates and rising risks of lockdowns," Michael McCarthy, chief markets strategist at CMC Markets, told Reuters.

"At the moment, the market seems to be quite lively and happy to rally on despite those increasing economic risks."

There are over 13.2 million cases globally as of July 15, according to Johns Hopkins University data.

Hong Kong’s Hang Seng Index was up 0.05% by 10:42 PM ET (3:42 AM GMT). Meanwhile, tensions between the U.S. and China continue to simmer after U.S. President Donald Trump issued the order to end Hong Kong’s preferential trade status on Tuesday. Trump also gave the green light to legislation sanctioning Chinese entities involved with enacting the city’s national security laws.

China’s Shanghai Composite slid 1.29%, and the Shenzhen Component was down 0.18% after reversing earlier gains.

Japan’s Nikkei 225 rose 1.27%. The Bank of Japan will release its policy statement, widely expected to remain unchanged, later in the day.

Tokyo also continues to deal with a fresh outbreak of COVID-19 cases in the city, with the alert level raised to the highest of four levels earlier in the day. The number of daily cases exceeded 200 for four of the past six days, with a record 243 cases reported on Friday.

South Korea’s KOSPI gained 0.62% and the ASX 200 rose 1.18%.

Some investors remained optimistic about equity’s latest rally.

Julius Baer Asia chief investment officer Bhaskar Laxminarayan told CNBC, Asia’s markets are “taking the cues from the global environment. Equities in general ... is the only game in town. Chances of making any kind of return on a risk-adjusted basis really rests on the shoulders of equities now.”

Latest comments

They will Soon find out About the fake vaccine news
So sell at open tomorrow? You think its gonna tank again?
I don't think so...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.